Neueste Storys

Filtern
  • 19.04.2021 – 15:01

    Vivera

    Third largest European plant based producer Vivera acquired by JBS S.A.

    São Paulo (ots/PRNewswire) - Purchase of Vivera, Europe's third-largest plant-based protein producer thrusts JBS into the plant protein market; the EUR341 million deal includes the three manufacturing units and a research and development center in The Netherlands JBS, the world's largest protein company and second-largest food producer, has entered into an agreement ...

  • 19.04.2021 – 11:47

    Vidac Pharma LTD

    Vidac Pharma Secures EUR 20m Capital Commitment From GEM

    Ness-Ziona, Israel (ots/PRNewswire) - Vidac Pharma LTD (Vidac) a clinical-stage Israel biopharmaceutical company, announced today that it has signed an agreement with GEM Global Yield LLC SCS ("GEM") a Luxemburg-based private alternative investment group for a EUR 20 million capital commitment. Under the agreement, GEM commits to provide Vidac with a share subscription facility of up to EUR 20 million for a 36-month term ...

  • 16.04.2021 – 20:06

    Mindtree

    /C O R R E C T I O N -- Mindtree/

    Bangalore, India and Warren, N.j. (ots/PRNewswire) - In the news release, Mindtree reports robust revenue growth of 5.2% q-o-q in USD; Recommends final dividend of INR17.5 per share, issued 16-Apr-2021 by Mindtree over PR Newswire, we are advised by the company that under the heading "Quarter ended March 31, 2021," the fourth bullet point should read "Net profit at INR3,173 million (decline of 2.8% q-o-q / growth of 53.9% y-o-y)" rather than "Net profit at INR3,173 million ...

  • 15.04.2021 – 08:00

    Schweizerischer Nationalfonds / Fonds national suisse

    Novel antibiotic deceives bacteria through mimicry

    Bern (ots) - Most antibiotics need to penetrate their target bacteria. But Darobactin, a newly discovered compound, is much too large to do so. Nonetheless, it kills many antibiotic-resistant pathogens - by exploiting a tiny weak spot on their surface. Basel researchers have now revealed the amazing mechanism at play and thereby opened the door to developing completely new medicines. An increasing number of bacterial ...